Lead Product(s) : Oxytocin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Monash University
Deal Size : $1.0 million
Deal Type : Collaboration
Iconovo Signs Agreement for Development of Inhaled Oxytocin in ICOone For Maternal Health
Details : The agreement gives Monash an exclusive global right to use ICOone with oxytocin to prevent postpartum haemorrhage in women giving birth.
Product Name : ICOone
Product Type : Hormone
Upfront Cash : Undisclosed
December 21, 2020
Lead Product(s) : Oxytocin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Monash University
Deal Size : $1.0 million
Deal Type : Collaboration